as of 7 april 2020, the who had accepted two diagnostic tests under the emergency use listing procedure (eul) for use during the covid‑19 pandemic. both in vitro diagnostics, the tests are genesig real-time pcr coronavirus (covid‑19) created by primerdesign, and cobas sars-cov-2 qualitative assay for use on the cobas® 6800/8800 systems by roche molecular systems. approval means that these tests can also be given away by the united nations.